Senior insider sale
EVP, CHIEF SCIENTIFIC OFFICER at EDITAS MEDICINE, INC. — senior position signals high conviction
$16.2K
6.65K shares
What this filing means
BURKLY LINDA plans to sell 6.65K shares of EDITAS MEDICINE, INC. valued at approximately $16.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/29/2025ACC: 0001650664-25-000128
Officer· EVP, CHIEF SCIENTIFIC OFFICER
Since Mar 2026
6.65K
Shares to sell
$16.2K
Approx. market value
1.55K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
9/2/2025
1.55KTotal acquired1.55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/2/2025 | Restricted Stock Unit Vesting Equity Compensation | 1.55K | — |
| Total | 1.55K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.12K
Market value
$12.8K
7/31/2025
—Completed
Units to sell
726.00
Market value
$1.3K
6/3/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
800.00
Market value
$2.2K
9/3/2025
Total
Units
6.65K
Value
$16.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/31/2025 | 5.12K | $12.8K | — | Completed |
6/3/2025 | 726.00 | $1.3K | — | Completed |
| Planned — Approximate Date | ||||
9/3/2025 | 800.00 | $2.2K | Nasdaq | Planned |
| Total | 6.65K | $16.2K | ||